Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glottic Nebulization of Budesonide and Lidocaine for Postoperative Sore Throat in Thyroid Surgery
NCT07491991Phase 4Completed
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Mar 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of budesonide and lidocaine in postoperative sore throat (POST) (2 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoint: Incidence of postoperative sore throat at 24 hours. Started Mar 2025; status: completed.
02
Drugs
budesonidelidocaine
03
Conditions
postoperative sore throat (POST)
Beyond the preview
Go deeper on NCT07491991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07491991.